Prognostic significance of BCL-2 expression in patients with multiple myeloma.

被引：0
|
作者：
Hashmi, M
Kojouri, K
Yang, J
Patel, S
Khan, M
Sylvester-Kohrt, N
Kamble, R
Selby, GB
Ozer, H
Kharfan-Dabaja, MA
机构：
[1] Univ Oklahoma, Hematol Oncol Sect, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Ctr Canc, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4840
引用
收藏
页码：292B / 293B
页数：2
相关论文
共 50 条
  • [1] Targeting Bcl-2 as therapy for multiple myeloma.
    Chauhan, D
    Velankar, M
    Hideshima, T
    Mitsiades, C
    Catley, L
    Raje, N
    Schlossman, R
    Richardson, P
    Anderson, KC
    BLOOD, 2005, 106 (11) : 36A - 36A
  • [2] Evaluation of Bcl-2 antisense oligonucleotide drugs in multiple myeloma.
    Van de Donk, N
    Kamphuis, M
    van Dijk, M
    de Weerd, O
    Lokhorst, H
    Bloem, A
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [3] Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus
    Y-L Zhai
    T Nikaido
    T Toki
    A Shiozawa
    A Orii
    S Fujii
    British Journal of Cancer, 1999, 80 : 1658 - 1664
  • [4] Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus
    Zhai, YL
    Nikaido, T
    Toki, T
    Shiozawa, A
    Orii, A
    Fujii, S
    BRITISH JOURNAL OF CANCER, 1999, 80 (10) : 1658 - 1664
  • [5] Bcl-2, Mcl-1 and p53 expression confer sensitivity to Bcl-2 inhibitor ABT-737 in multiple myeloma.
    Chauhan, Dharminder
    Brahmandam, Mohan
    Hideshima, Teru
    Podar, Klaus
    Munshi, Nikhil
    Raje, Noopur
    Anderson, Kenneth C.
    BLOOD, 2006, 108 (11) : 991A - 991A
  • [6] The expression and clinical significance of survivin in multiple myeloma.
    Li, J
    Zhao, Y
    Zhang, DB
    Haung, BH
    BLOOD, 2005, 106 (11) : 348B - 348B
  • [7] Expression and clinical significance of β-catenin in multiple myeloma.
    Li, Juan
    Zhang, Dian-Bao
    Luo, Shao-kai
    Zhao, Ying
    Huang, Bei-Hui
    Gu, Jing-Li
    BLOOD, 2006, 108 (11) : 341B - 341B
  • [8] Bcl-2 expression in malignant melanoma and its prognostic significance
    Grover, R
    Wilson, GD
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (04): : 347 - 349
  • [9] Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma
    Bila, Jelena
    Sretenovic, Aleksandra
    Jelicic, Jelena
    Tosic, Natasa
    Glumac, Irena
    Fekete, Marija Dencic
    Antic, Darko
    Balint, Milena Todorovic
    Markovic, Olivera
    Milojevic, Zoran
    Radojkovic, Milica
    Trajkovic, Goran
    Puric, Mila
    Pavlovic, Sonja
    Mihaljevic, Biljana
    Clinical Lymphoma Myeloma & Leukemia, 2016, 16 (11): : 610 - 615
  • [10] Prognostic significance of detectable rearrangements of T cell receptors γ in patients with multiple myeloma.
    Garicochea, B
    Borioli, RA
    Bendit, I
    Martinez, GA
    BLOOD, 2002, 100 (11) : 374B - 374B
12345